LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged optics · clear

PTAB

Unforced Error: An IPR Challenger Cannot Rely on an Error That a Posita Would Have Corrected

LG ELECTRONICS INC. v. IMMERVISION INC. Before Stoll , Cunningham, and Newman, Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board. Summary : Where a reference contains an “obvious” error in a disclosure,…

July 12, 2022·PTAB·2 min read
PTAB

Claims Survive IPR Challenge Under Narrow Construction Because It Was The Broadest Reasonable Interpretation

QUANERGY SYSTEMS, INC. v. VELODYNE LIDAR USA, INC. Before Newman, Lourie, and O’Malley . Appeal from the Patent Trial and Appeal Board. Summary: Despite applying the standard of broadest reasonable construction, a claim term’s narrowed…

February 7, 2022·PTAB·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.